Kay G. Balster

Principal / Authorized signatory

Kay Balster is one of High-Tech Gründerfonds’s longest-serving employees. Since 2009 he has been focusing on financing start-ups from the biotechnology and medical technology sectors. He can draw on 20 years of experience in advising technology start-ups, while his background in economics, training as a banker and especially the day-to-day interaction he has with the founders in his HTGF portfolio help him in his role.

When he is not working, family time and sport are his top priorities.

Portfolio

Exit

Posts & mentions

Press

1. August 2023

Bind-X secures €10 million in financing as part of its Series B financing round

Specialist in biological binding of materials expands internationally and prepares further market entries in agriculture, mining, and infrastructure. Martinsried, 1st of August 2023 – Bind-X, a fast-growing industrial biotechnology company, has successfully closed a €10 million financing round. The funding was provided by renowned investors from Germany and abroad (HG Ventures, K&K 1, Greeneering Invest, Saxovent) and will help drive the decarbonization and biologization of es